Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.25B |
| 2 |
CSX Corp
CSX
|
+$1.25B |
| 3 |
Verizon
VZ
|
+$935M |
| 4 |
Micron Technology
MU
|
+$925M |
| 5 |
Harley-Davidson
HOG
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$1.51B |
| 2 |
Philip Morris
PM
|
+$1.36B |
| 3 |
American International
AIG
|
+$1.25B |
| 4 |
McKesson
MCK
|
+$1.11B |
| 5 |
Caterpillar
CAT
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.27% |
| 2 | Technology | 16.26% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Financials | 11.32% |
| 5 | Communication Services | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVP
226
DELISTED
Avon Products, Inc.
AVP
| $203M | 0.06% |
53,379,963
| – | – |
|
227
Motorola Solutions
MSI
$77B
| $199M | 0.06% |
2,298,922
+1,551
| +0.1% | +$132K |
|
228
Range Resources
RRC
$9.31B
| $197M | 0.06% |
8,507,229
-405,998
| -5% | -$10.2M |
|
|
SWN
229
DELISTED
Southwestern Energy Company
SWN
| $197M | 0.06% |
32,358,150
-19,320,231
| -37% | -$133M |
|
230
TJX Companies
TJX
$169B
| $196M | 0.06% |
5,421,250
+956
| +0% | +$36K |
|
231
Landstar System
LSTR
$6.4B
| $195M | 0.06% |
2,279,428
+1,828
| +0.1% | +$155K |
|
|
NEE.PRR
232
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $194M | 0.06% |
3,600,000
| – | – |
|
|
DCUD
233
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $194M | 0.06% |
3,855,302
| – | – |
|
234
Kosmos Energy
KOS
$1.5B
| $193M | 0.06% |
30,153,256
+4,130,107
| +16% | +$26.2M |
|
235
Lamb Weston
LW
$7.45B
| $192M | 0.06% |
4,366,397
-316,692
| -7% | -$13.9M |
|
236
PPG Industries
PPG
$25.5B
| $192M | 0.06% |
+1,748,145
| New | +$189M |
|
|
GRFS
237
Grifois
GRFS
$5.42B
| $192M | 0.06% |
9,095,819
-773,216
| -8% | -$16.2M |
|
238
Novartis
NVS
$288B
| $189M | 0.06% |
2,520,492
| – | – |
|
239
Teck Resources
TECK
$31.2B
| $188M | 0.06% |
10,823,532
-9,503,220
| -47% | -$182M |
|
240
Generac Holdings
GNRC
$12.8B
| $187M | 0.06% |
5,172,341
-51,529
| -1% | -$1.84M |
|
241
Occidental Petroleum
OXY
$57.7B
| $180M | 0.06% |
+3,000,000
| New | +$184M |
|
|
IPHI
242
DELISTED
INPHI CORPORATION
IPHI
| $174M | 0.05% |
5,064,201
+180,367
| +4% | +$7.25M |
|
243
Viavi Solutions
VIAV
$10.5B
| $171M | 0.05% |
16,251,481
+352,207
| +2% | +$3.79M |
|
|
WCG
244
DELISTED
Wellcare Health Plans, Inc.
WCG
| $170M | 0.05% |
+946,990
| New | +$157M |
|
245
BWX Technologies
BWXT
$15.6B
| $169M | 0.05% |
3,464,262
+345,797
| +11% | +$16.8M |
|
246
Hilton Grand Vacations
HGV
$3.46B
| $169M | 0.05% |
4,678,200
+319,000
| +7% | +$11M |
|
247
Xcel Energy
XEL
$49.3B
| $166M | 0.05% |
3,615,000
| – | – |
|
248
Texas Capital Bancshares
TCBI
$4.39B
| $165M | 0.05% |
2,127,895
+445,248
| +26% | +$34.3M |
|
|
PRAH
249
DELISTED
PRA Health Sciences, Inc.
PRAH
| $163M | 0.05% |
2,175,340
+1,655,336
| +318% | +$115M |
|
|
CHK
250
DELISTED
Chesapeake Energy Corporation
CHK
| $161M | 0.05% |
162,436
| – | – |
|
Similar funds
Capital Research Global Investors's Q2 2017 Portfolio in Review
As of Q2 2017, Capital Research Global Investors held 454 positions worth $319B, up 0.77% from $317B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Capital Research Global Investors's Q2 2017 filing shows 29 new, 155 increased, 158 reduced and 23 closed positions. Its largest new stake was L3Harris: 2,791,603 shares worth $305M. The largest sale was Union Pacific, an estimated $1.51B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2017 buy was L3Harris: 2,791,603 shares worth $305M.
- Capital Research Global Investors added most to Microsoft in Q2 2017, an estimated $3.25B increase.
- Capital Research Global Investors's biggest Q2 2017 reduction was Union Pacific, cutting an estimated $1.51B.
- Capital Research Global Investors fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $525M.
- Capital Research Global Investors's ten largest holdings make up 24% of its $319B portfolio in Q2 2017.
- Capital Research Global Investors opened 29 new positions and closed 23 in Q2 2017.
- Capital Research Global Investors's portfolio value rose 0.77% quarter-over-quarter to $319B.
Based on Capital Research Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.